Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
309.03
-1.27 (-0.41%)
At close: May 29, 2026, 4:00 PM EDT
305.00
-4.03 (-1.30%)
After-hours: May 29, 2026, 7:59 PM EDT

Krystal Biotech Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Krystal Biotech stock has a consensus rating of "Strong Buy" and an average price target of $322.78. The average 1-year stock price forecast is 4.45% higher than the current stock price, while the lowest is $241 (-22.01%) and the highest is $399 (+29.11%).

Price Target: $322.78 (+4.45%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$241$322.78$310$399
Change-22.01%+4.45%+0.31%+29.11%

Analyst Ratings

The average analyst rating for Krystal Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy10111010109
Buy000000
Hold100111
Sell000000
Strong Sell000000
Total111110111110

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Maintains
$325$364
BuyMaintains$325$364+17.79%May 22, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$310
BuyReiterates$310+0.31%May 22, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 18, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$295$300
BuyMaintains$295$300-2.92%May 5, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$284
BuyReiterates$284-8.10%May 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
539.50M
from 389.13M
Increased by 38.64%
Revenue Next Year
691.16M
from 539.50M
Increased by 28.11%
EPS This Year
8.09
from 6.84
Increased by 18.21%
EPS Next Year
10.15
from 8.09
Increased by 25.53%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
--50.70M290.52M389.13M539.50M691.16M
Revenue Growth
---473.02%33.95%38.64%28.11%
EPS
-3.13-5.490.393.006.848.0910.15
EPS Growth
---669.23%128.00%18.21%25.53%
Forward PE
-----38.2230.45
No. Analysts
-----1413
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030203120322033
High588.0M759.1M
Avg539.5M691.2M
Low484.1M628.4M

Revenue Growth

Revenue Growth20262027202820292030203120322033
High
51.1%
40.7%
Avg
38.6%
28.1%
Low
24.4%
16.5%

EPS Forecast

EPS2026202720282029203020312032
High9.6214.09
Avg8.0910.15
Low6.096.53

EPS Growth

EPS Growth2026202720282029203020312032
High
40.6%
74.3%
Avg
18.2%
25.5%
Low
-11.0%
-19.3%
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.